{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:24Z","timestamp":1791316704670,"version":"4.3.1"},"reference-count":24,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,12,8]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.270233","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:50:15Z","timestamp":1767891015000},"page":"506-513","source":"Crossref","is-referenced-by-count":2,"title":["Malignancy Detection Rates of [\n                    <sup>68<\/sup>\n                    Ga]Ga-SSO120 PET\/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Tine N.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo W.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Dejanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gillings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune H.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Albrecht-Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2026040105551059000_67.4.506.1","unstructured":"Danish Lung Cancer Registry annual report 2022 [in Danish]. Danish Healthcare Quality Institute website. https:\/\/www.sundk.dk\/media\/54lhcg4f\/9cab2e132e434b56896364f4538a1104.pdf. Published June 23, 2023. Accessed December 22, 2025."},{"key":"2026040105551059000_67.4.506.2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.tranon.2019.01.004","article-title":"Large Cell neuroendocrine carcinoma shares similarity with small cell carcinoma on the basis of clinical and pathological features","volume":"12","author":"Xu","year":"2019","journal-title":"Transl Oncol."},{"key":"2026040105551059000_67.4.506.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.03.207"},{"key":"2026040105551059000_67.4.506.4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/jcm11051461","article-title":"Large cell neuroendocrine carcinoma of the lung: current understanding and challenges","volume":"11","author":"Andrini","year":"2022","journal-title":"J Clin Med."},{"key":"2026040105551059000_67.4.506.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0110-y"},{"key":"2026040105551059000_67.4.506.6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/0284186X.2023.2212411","article-title":"Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms","volume":"62","author":"Dam","year":"2023","journal-title":"Acta Oncol."},{"key":"2026040105551059000_67.4.506.7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31771"},{"key":"2026040105551059000_67.4.506.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3728-y"},{"key":"2026040105551059000_67.4.506.9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7706"},{"key":"2026040105551059000_67.4.506.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199760"},{"key":"2026040105551059000_67.4.506.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.138834"},{"key":"2026040105551059000_67.4.506.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.186783"},{"key":"2026040105551059000_67.4.506.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.199737"},{"key":"2026040105551059000_67.4.506.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265664"},{"key":"2026040105551059000_67.4.506.15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40658-016-0146-3","article-title":"Cross-calibration of the Siemens mMR: easily acquired accurate PET phantom measurements, long-term stability and reproducibility","volume":"3","author":"Keller","year":"2016","journal-title":"EJNMMI Phys."},{"key":"2026040105551059000_67.4.506.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.238923"},{"key":"2026040105551059000_67.4.506.17","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007628"},{"key":"2026040105551059000_67.4.506.18","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.7150\/thno.98819","article-title":"Theranostics with somatostatin receptor antagonists in SCLC: correlation of 68Ga-SSO120 PET with immunohistochemistry and survival","volume":"14","author":"Mavroeidi","year":"2024","journal-title":"Theranostics."},{"key":"2026040105551059000_67.4.506.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261936"},{"key":"2026040105551059000_67.4.506.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264890"},{"key":"2026040105551059000_67.4.506.21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00259-023-06383-1","article-title":"A phase I\/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours","volume":"51","author":"Wild","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551059000_67.4.506.22","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s00259-024-06682-1","article-title":"Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours","volume":"51","author":"Schurrle","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551059000_67.4.506.23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2967\/jnumed.117.206631","article-title":"SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: a proposed standardization framework","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med."},{"key":"2026040105551059000_67.4.506.24","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00259-020-04832-9","article-title":"Comparison of 68Ga-DOTA-JR11 PET\/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT\/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy","volume":"47","author":"Krebs","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:17:46Z","timestamp":1785269866000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.270233"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270233","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}